Source: Health Products Regulatory Authority (IE) Revision Year: 2017 Publisher: Rowex Ltd, Bantry, Co. Cork
Emazole 20 mg Gastro-Resistant Tablets.
Pharmaceutical Form |
---|
Gastro-resistant tablet. 20 mg: Light pink oval film-coated tablet. |
Each gastro-resistant tablet contains 20 mg esomeprazole (as magnesium dihydrate).
Excipient(s) with known effect: Each 20 mg gastro-resistant tablet contains 12.90 mg – 14.76 mg sucrose and 0.81 mg glucose.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Esomeprazole |
Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion. |
List of Excipients |
---|
Tablet core: Sucrose Tablet coating: Hypromellose |
Aluminium/aluminium blisters and aclar/aluminium blisters with 7, 14, 15, 28, 30, 56, 60, 90, 98, 100 and 100 × 1 gastro-resistant tablets.
HDPE bottles with PP cap and desiccant with 7, 14, 15, 28, 30, 56, 60, 90, 98, 100 and 250 gastro-resistant tablets.
Not all pack sizes may be marketed.
Rowex Ltd, Bantry, Co. Cork
PA0711/158/001
Date of first authorisation: 8th April 2009
Date of last renewal: 2nd April 2014
Drug | Countries | |
---|---|---|
EMAZOLE | Ireland, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.